117 related articles for article (PubMed ID: 38846124)
21. Attitudes, practices, and determinants of community care-seeking behaviours for fever/malaria episodes in the context of the implementation of multiple first-line therapies for uncomplicated malaria in the health district of Kaya, Burkina Faso.
Kaboré JMT; Siribié M; Hien D; Soulama I; Barry N; Nombré Y; Dianda F; Baguiya A; Tiono AB; Burri C; Tchouatieu AM; Sirima SB
Malar J; 2022 May; 21(1):155. PubMed ID: 35637506
[TBL] [Abstract][Full Text] [Related]
22. Comparison of all-cause and malaria-specific mortality from two West African countries with different malaria transmission patterns.
Ndugwa RP; Ramroth H; Müller O; Jasseh M; Sié A; Kouyaté B; Greenwood B; Becher H
Malar J; 2008 Jan; 7():15. PubMed ID: 18205915
[TBL] [Abstract][Full Text] [Related]
23. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
[TBL] [Abstract][Full Text] [Related]
24. Hospital-based surveillance of severe paediatric malaria in two malaria transmission ecological zones of Burkina Faso.
Tiono AB; Konaté AT; Kargougou D; Diarra A; Ouedraogo IN; Ouedraogo A; Pagnoni F; Modiano D; Sirima SB
Malar J; 2023 Jan; 22(1):6. PubMed ID: 36609299
[TBL] [Abstract][Full Text] [Related]
25. Uneven malaria transmission in geographically distinct districts of Bobo-Dioulasso, Burkina Faso.
Soma DD; Kassié D; Sanou S; Karama FB; Ouari A; Mamai W; Ouédraogo GA; Salem G; Dabiré RK; Fournet F
Parasit Vectors; 2018 May; 11(1):296. PubMed ID: 29751825
[TBL] [Abstract][Full Text] [Related]
26. Nutritional status in young children prior to the malaria transmission season in Burkina Faso and Mali, and its impact on the incidence of clinical malaria.
de Wit M; Cairns M; Compaoré YD; Sagara I; Kuepfer I; Zongo I; Barry A; Diarra M; Tapily A; Coumare S; Thera I; Nikiema F; Yerbanga RS; Guissou RM; Tinto H; Dicko A; Chandramohan D; Greenwood B; Ouedraogo JB
Malar J; 2021 Jun; 20(1):274. PubMed ID: 34158054
[TBL] [Abstract][Full Text] [Related]
27. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
28. Using LiST to model potential reduction in under-five mortality in Burkina Faso.
Marsh A; Munos M; Baya B; Sanon D; Gilroy K; Bryce J
BMC Public Health; 2013; 13 Suppl 3(Suppl 3):S26. PubMed ID: 24564341
[TBL] [Abstract][Full Text] [Related]
29. Investigating selected host and parasite factors potentially impacting upon seasonal malaria chemoprevention in Bama, Burkina Faso.
Somé FA; Bazié T; Ehrlich HY; Goodwin J; Lehane A; Neya C; Zachari K; Wade M; Ouattara JM; Foy BD; Dabiré RK; Parikh S; Ouédraogo JB
Malar J; 2020 Jul; 19(1):238. PubMed ID: 32631416
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the implementation fidelity of the seasonal malaria chemoprevention intervention in Kaya health district, Burkina Faso.
Compaoré R; Yameogo MWE; Millogo T; Tougri H; Kouanda S
PLoS One; 2017; 12(11):e0187460. PubMed ID: 29186137
[TBL] [Abstract][Full Text] [Related]
31. Frequency of severe malaria and invasive bacterial infections among children admitted to a rural hospital in Burkina Faso.
Maltha J; Guiraud I; Kaboré B; Lompo P; Ley B; Bottieau E; Van Geet C; Tinto H; Jacobs J
PLoS One; 2014; 9(2):e89103. PubMed ID: 24551225
[TBL] [Abstract][Full Text] [Related]
32. Delivery of seasonal malaria chemoprevention with enhanced infection prevention and control measures during the COVID-19 pandemic in Nigeria, Burkina Faso and Chad: a cross-sectional study.
Ward C; Phillips A; Oresanya O; Olisenekwu G; Arogunade E; Moukénet A; Beakgoubé H; De Paul Allambademel V; Compaoré CS; Traoré A; Ouedraogo JB; Compaoré YD; Zongo I; Donovan L; Decola MA; Smith H; Baker K
Malar J; 2022 Mar; 21(1):103. PubMed ID: 35331248
[TBL] [Abstract][Full Text] [Related]
33. Malaria in Burkina Faso: A comprehensive analysis of spatiotemporal distribution of incidence and environmental drivers, and implications for control strategies.
Bationo C; Cissoko M; Katilé A; Sylla B; Ouédraogo A; Ouedraogo JB; Tougri G; Kompaoré SCB; Moiroux N; Gaudart J
PLoS One; 2023; 18(9):e0290233. PubMed ID: 37703223
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of Olyset Duo, a bednet containing pyriproxyfen and permethrin, versus a permethrin-only net against clinical malaria in an area with highly pyrethroid-resistant vectors in rural Burkina Faso: a cluster-randomised controlled trial.
Tiono AB; Ouédraogo A; Ouattara D; Bougouma EC; Coulibaly S; Diarra A; Faragher B; Guelbeogo MW; Grisales N; Ouédraogo IN; Ouédraogo ZA; Pinder M; Sanon S; Smith T; Vanobberghen F; Sagnon N; Ranson H; Lindsay SW
Lancet; 2018 Aug; 392(10147):569-580. PubMed ID: 30104047
[TBL] [Abstract][Full Text] [Related]
35. Association of malaria and curable sexually transmitted infections with pregnancy outcomes in rural Burkina Faso.
Zango SH; Lingani M; Valea I; Samadoulougou OS; Bihoun B; Lankoande D; Donnen P; Dramaix M; Tinto H; Robert A
BMC Pregnancy Childbirth; 2021 Oct; 21(1):722. PubMed ID: 34706705
[TBL] [Abstract][Full Text] [Related]
36. Impact Evaluation of Seasonal Malaria Chemoprevention under Routine Program Implementation: A Quasi-Experimental Study in Burkina Faso.
Druetz T; Corneau-Tremblay N; Millogo T; Kouanda S; Ly A; Bicaba A; Haddad S
Am J Trop Med Hyg; 2018 Feb; 98(2):524-533. PubMed ID: 29260654
[TBL] [Abstract][Full Text] [Related]
37. [Risk factors for death from severe malaria in children at the Charles de Gaulle pediatric hospital of Ouagadougou (Burkina Faso)].
Kouéta F; Dao L; Yé D; Zoungrana A; Kaboré A; Sawadogo A
Sante; 2007; 17(4):195-9. PubMed ID: 18299261
[TBL] [Abstract][Full Text] [Related]
38. [Monitoring of adverse drug reactions during seasonal malaria chemoprevention campaigns in children aged 3–59 months in Burkina Faso].
Ouoba J; Lankoandé-Haro S; Fofana S; Nacoulma AP; Kaboré L; Sombié I; Rouamba T; Kirakoya-Samadoulougou F
Sante Publique; 2024 Jan; 35(5):121-132. PubMed ID: 38172043
[TBL] [Abstract][Full Text] [Related]
39. Treatable causes of fever among children under five years in a seasonal malaria transmission area in Burkina Faso.
Kiemde F; Tahita MC; Lompo P; Rouamba T; Some AM; Tinto H; Mens PF; Schallig HDFH; van Hensbroek MB
Infect Dis Poverty; 2018 May; 7(1):60. PubMed ID: 29891004
[TBL] [Abstract][Full Text] [Related]
40. Challenges and opportunities associated with the introduction of next-generation long-lasting insecticidal nets for malaria control: a case study from Burkina Faso.
Tesfazghi K; Traore A; Ranson H; N'Fale S; Hill J; Worrall E
Implement Sci; 2016 Jul; 11():103. PubMed ID: 27450082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
